US biotech company Moderna announced Monday that its coronavirus vaccine candidate is 94.5% effective in fighting the virus, according to initial analysis..
US biotech company Moderna announced Monday that its coronavirus vaccine candidate is 94.5% effective in fighting the virus, according to initial analysis released by the company.
The announcement comes just days after pharmaceutical company Pfizer announced similarly effective results from their vaccine. These new developments provide glimmers of hope that the pandemic currently raging across the world could be tamed by next year.
“This is a pivotal moment in the development of our COVID-19 vaccine candidate. Since early January, we have chased this virus with the intent to protect as many people around the world as possible. All along, we have known that each day matters. This positive interim analysis has given us the first clinical validation that our vaccine can prevent COVID-19 disease, including severe disease,” Moderna said in a statement.
“These are obviously very exciting results,” Dr. Anthony Fauci said. “It’s just as good as it gets — 94.5% is truly outstanding.”
Based on these interim safety and efficacy data, Moderna intends to request an emergency use authorization from the FDA in the coming weeks. Moderna also plans to submit applications for authorizations to global regulatory agencies.
In keeping in line with the Rabbonim's policies for websites, we do not allow comments. However, our Rabbonim have approved of including input on articles of substance (Torah, history, memories etc.)
We appreciate your feedback. If you have any additional information to contribute to this article, it will be added below.